We may think we’re done with COVID-19, but COVID-19 is not done with us As we approach a new presidential administration and a new Congress, we cannot regard COVID-19 as one of several respiratory diseases that can be dealt with through a vaccination program and other … ckulat The Hill

As we approach a new presidency, a new Congress and new leaders in our health agencies, I am concerned that the sense of urgency about COVID-19 appears to have faded. The disease has not been discussed during the election season, even though it is an ongoing and developing public health threat.

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID Paxlovid was associated with a 61% lower risk of hospitalization. CIDRAP

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.